Federal Register / Vol. 60, No. 249 / Thursday, December 28, 1995 / Notices 67141

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Importation of Controlled Substances;

Notice of Application

Pursuant to Section 1008 of the

Controlled Substances Import and

Export Act (21 U.S.C. 958(i)), the

Attorney General shall, prior to issuing

a registration under this Section to a

bulk manufacturer of a controlled

substance in Schedule I or II and prior

to issuing a regulation under Section

1002(a) authorizing the importation of

such a substance, provide

manufacturers holding registrations for

the bulk manufacture of the substance

an opportunity for a hearing.

Therefore, in accordance with Section

1311.42 of Title 21, Code of Federal

Regulations (CFR), notice is hereby

given that on October 11, 1995, The

Binding Site, Inc., 5889 Oberlin Drive,

Suite 101, San Diego, California 92121,

made application to the Drug

Enforcement Administration to be

registered as an importer of the basic

classes of controlled substances listed

below:

Drug Schedule

Methaqualone (2565) ................... I

Lysergic acid diethylamide (7315) I

Tetrahydrocannabinols (7370) ..... I

Normorphine (9313) ..................... I

Methamphetamine (1105) ............ II

Amobarbital (2125) ...................... II

Secobarbital (2315) ...................... II

Ecgonine (9130) ........................... II

Ethylmorphine (9190) ................... II

Meperidine intermediate-C (9234) II

The firm plans to import the above

listed substances in milligrams

quantities for labelling with enzymes,

fluorophores and radioisotopes for

immunoassays.

Any manufacturer holding, or

applying for, registration as a bulk

manufacturer of this basic class of

controlled substance may file written

comments on or objections to the

application described above and may, at

the same time, file a written request for

a hearing on such application in

accordance with 21 CFR 1301.54 in

such form as prescribed by 21 CFR

1316.47.

Any such comments, objections, or

requests for a hearing may be addressed

to the Deputy Assistant Administrator,

Office of Diversion Control, Drug

Enforcement Administration, United

States Department of Justice,

Washington, D.C. 20537, Attention: DEA

Federal Register Representative (CCR),

and must be filed no later than January

29, 1996.

This procedure is to be conducted

simultaneously with and independent

of the procedures described in 21 CFR

1311.42(b), (c), (d), (e), and (f). As noted

in a previous notice at 40 FR 43745–46

(September 23, 1975), all applicants for

registration to import a basic class of

any controlled substance in Schedule I

or II are and will continue to be required

to demonstrate to the Deputy Assistant

Administrator, Office of Diversion

Control, Drug Enforcement

Administration that the requirements

for such registration pursuant to 21

U.S.C. 958(a), 21 U.S.C. 823(a), and 21

CFR 1311.42(a), (b), (c), (d), (e), and (f)

are satisfied.

Dated: December 15, 1995.

Gene R. Haislip,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 95–31389 Filed 12–27–95; 8:45 am]

BILLING CODE 4410–09–M

Importer of Controlled Substances;

Notice of Registration

By Notice dated August 10, 1995, and

published in the Federal Register on

August 17, 1995 (60 FR 42905),

Noramco of Delaware, Inc., Division of

McNeilab, Inc., 500 Old Swedes

Landing Road, Wilmington, Delaware

19801, made application to the Drug

Enforcement Administration (DEA) to

be registered as an importer of basic

classes of controlled substances listed

below:

Drug Schedule

Opium, raw (9600) ....................... II

Poppy Straw Concentrate (9670) II

No comments or objections have been

received. DEA has determined that the

registration of Noramco of Delaware,

Inc. to import the listed controlled

substances is consistent with the public

interest at this time. Therefore, pursuant

to Section 1008(a) of the Controlled

Substances Import and Export Act and

in accordance with Title 21, Code of

Federal Regulations, Section 1311.42,

the above firm is granted registration as

an importer of the basic classes of

controlled substances listed above.

Dated: December 15, 1995.

Gene R. Haislip,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 95–31387 Filed 12–27–95; 8:45 am]

BILLING CODE 4410–09–M

Importation of Controlled Substances;

Notice of Application

Pursuant to Section 1008 of the

Controlled Substances Import and

Export Act (21 U.S.C. 958(i)), the

Attorney General shall, prior to issuing

a registration under this Section to a

bulk manufacturer of a controlled

substance in Schedule I or II and prior

to issuing a regulation under Section

1002(a) authorizing the importation of

such a substance, provide

manufacturers holding registrations for

the bulk manufacture of the substance

an opportunity for a hearing.

Therefore, in accordance with

§ 1311.42 of Title 21, Code of Federal

Regulations (CFR), notice is hereby

given that on October 23, 1995, North

Pacific Trading Company, 1505 SE

Gideon Street, Portland, Oregon 97202,

made application to the Drug

Enforcement Administration to be

registered as an importer of marihuana

(7360) a basic class of controlled

substance in Schedule I.

This application is exclusively for the

importation of marihuana seed which

will be rendered non-viable and used as

bird seed.

Any manufacturer holding, or

applying for, registration as a bulk

manufacturer of these basic classes of

controlled substances may file written

comments on or objections to the

application described above and may, at

the same time, file a written request for

a hearing on such application in

accordance with 21 CFR 1301.54 in

such form as prescribed by 21 CFR

1316.47.

Any such comments, objections, or

requests for a hearing may be addressed

to the Deputy Assistant Administrator,

Office of Diversion Control, Drug

Enforcement Administration, United

States Department of Justice,

Washington, D.C. 20537, Attention: DEA

Federal Register Representative (CCR),

and must be filed no later than (30 days

from publication).

This procedure is to be conducted

simultaneously with and independent

of the procedures described in 21 CFR

1311.42 (b), (c), (d), (e), and (f). As noted

in a previous notice at 40 FR 43745–46

(September 23, 1975), all applicants for

registration to import basic classes of

any controlled substances in Schedule I

or II are and will continue to be required

to demonstrate to the Deputy Assistant

Administrator, Office of Diversion

Control, Drug Enforcement

Administration that the requirements

for such registration pursuant to 21

U.S.C. 958(a), 21 U.S.C. 823(a), and 21

CFR 1311.42 (a), (b), (c), (d), (e), and (f)

are satisfied.